• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Asymptomatic atrial fibrillation patients: DOAC or don't?

作者信息

Fitzpatrick Niall P

机构信息

GP, Eastham Group Practice. Wirral. Email:

出版信息

Br J Gen Pract. 2025 May 29;75(755):254. doi: 10.3399/bjgp25X742497. Print 2025 Jun.

DOI:10.3399/bjgp25X742497
PMID:40441904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12117631/
Abstract
摘要

相似文献

1
Asymptomatic atrial fibrillation patients: DOAC or don't?无症状性房颤患者：使用直接口服抗凝剂还是不使用？
Br J Gen Pract. 2025 May 29;75(755):254. doi: 10.3399/bjgp25X742497. Print 2025 Jun.
2
Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.在接受直接口服抗凝剂治疗的患者中，凝血筛选试验与特定检测方法的可比性较差：一项多中心/多平台研究的结果。
J Thromb Haemost. 2016 Nov;14(11):2194-2201. doi: 10.1111/jth.13486. Epub 2016 Oct 15.
3
Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.在非瓣膜性心房颤动的心源性栓塞性卒中患者中早期引入直接口服抗凝剂。
J Thromb Thrombolysis. 2016 Oct;42(3):393-8. doi: 10.1007/s11239-016-1393-9.
4
Association Between Inappropriately Dosed Anticoagulation Therapy With Stroke Severity and Outcomes in Patients With Atrial Fibrillation.抗凝治疗剂量不当与房颤患者卒中严重程度和结局的关系。
J Am Heart Assoc. 2022 Mar 15;11(6):e024402. doi: 10.1161/JAHA.121.024402. Epub 2022 Mar 1.
5
Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation.近期缺血性脑卒中合并心房颤动患者抗凝治疗的时机。
Lancet Neurol. 2019 Jan;18(1):117-126. doi: 10.1016/S1474-4422(18)30356-9. Epub 2018 Nov 8.
6
Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.直接口服抗凝剂治疗的心房颤动患者新型出血风险预测工具 DOAC 评分的制定与验证。
Circulation. 2023 Sep 19;148(12):936-946. doi: 10.1161/CIRCULATIONAHA.123.064556. Epub 2023 Aug 25.
7
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.急性缺血性卒中合并心房颤动后抗凝治疗的最佳时机（OPTIMAS）：一项多中心、盲终点、4期随机对照试验。
Lancet. 2024 Oct 23. doi: 10.1016/S0140-6736(24)02197-4.
8
Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.双腔起搏器和植入式心律转复除颤器指导下基于连续房颤负荷监测的间断抗凝治疗：来自非持续房颤个体化抗凝治疗（TACTIC-AF）试验的研究结果。
Heart Rhythm. 2018 Nov;15(11):1601-1607. doi: 10.1016/j.hrthm.2018.06.027. Epub 2018 Jul 6.
9
Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation.接受口服抗凝剂治疗心房颤动患者的生活质量、治疗满意度及依从性的真实生活体验。
Patient Prefer Adherence. 2018 Jan 4;12:79-87. doi: 10.2147/PPA.S131158. eCollection 2018.
10
Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin.直接口服抗凝药物在从华法林转换过来的房颤患者中的依从性。
J Am Heart Assoc. 2021 Dec 7;10(23):e020904. doi: 10.1161/JAHA.121.020904. Epub 2021 Nov 15.

本文引用的文献

1
Yonder: Screening for atrial fibrillation, antibiotics in care homes, hand, foot, and mouth disease, and asthma triple therapy.如下：心房颤动筛查、养老院中的抗生素使用、手足口病以及哮喘三联疗法。
Br J Gen Pract. 2025 Mar 27;75(753):180. doi: 10.3399/bjgp25X741273. Print 2025 Apr.
2
Risk-based screening for the evaluation of atrial fibrillation in general practice (R-BEAT): a randomized cross-over trial.基于风险的初级医疗中房颤评估筛查（R-BEAT）：一项随机交叉试验
QJM. 2025 Mar 1;118(3):166-173. doi: 10.1093/qjmed/hcaf001.
3
Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.直接口服抗凝剂预防器械检测到的心房颤动患者卒中：NOAH-AFNET 6 和 ARTESiA 试验的研究水平荟萃分析。
Circulation. 2024 Mar 26;149(13):981-988. doi: 10.1161/CIRCULATIONAHA.123.067512. Epub 2023 Nov 12.
4
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.阿哌沙班预防非瓣膜性心房颤动的卒中。
N Engl J Med. 2024 Jan 11;390(2):107-117. doi: 10.1056/NEJMoa2310234. Epub 2023 Nov 12.
5
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.在伴有心房快速发作的患者中使用依度沙班进行抗凝治疗。
N Engl J Med. 2023 Sep 28;389(13):1167-1179. doi: 10.1056/NEJMoa2303062. Epub 2023 Aug 25.
6
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.在外科患者抗血栓药物临床研究中主要出血的定义。
J Thromb Haemost. 2010 Jan;8(1):202-4. doi: 10.1111/j.1538-7836.2009.03678.x. Epub 2009 Oct 30.